|
Weinger, Jason G; Davies, Peter; Acker, Christopher M et al. (2012) Mice devoid of Tau have increased susceptibility to neuronal damage in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis. J Neuropathol Exp Neurol 71:422-33
|
|
Boutajangout, Allal; Ingadottir, Johanna; Davies, Peter et al. (2011) Passive immunization targeting pathological phospho-tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain. J Neurochem 118:658-67
|
|
Davies, Peter; Koppel, Jeremy (2009) Mechanism-based treatments for Alzheimer's disease. Dialogues Clin Neurosci 11:159-69
|
|
Herskovits, A Z; Davies, P (2006) The regulation of tau phosphorylation by PCTAIRE 3: implications for the pathogenesis of Alzheimer's disease. Neurobiol Dis 23:398-408
|
|
Marambaud, Philippe; Zhao, Haitian; Davies, Peter (2005) Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides. J Biol Chem 280:37377-82
|
|
Andorfer, Cathy; Kress, Yvonne; Espinoza, Marisol et al. (2003) Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms. J Neurochem 86:582-90
|
|
Ramakrishnan, Pankajavalli; Dickson, Dennis W; Davies, Peter (2003) Pin1 colocalization with phosphorylated tau in Alzheimer's disease and other tauopathies. Neurobiol Dis 14:251-64
|
|
Bu, Bitao; Li, Jin; Davies, Peter et al. (2002) Deregulation of cdk5, hyperphosphorylation, and cytoskeletal pathology in the Niemann-Pick type C murine model. J Neurosci 22:6515-25
|
|
Zamora-Leon, S P; Lee, G; Davies, P et al. (2001) Binding of Fyn to MAP-2c through an SH3 binding domain. Regulation of the interaction by ERK2. J Biol Chem 276:39950-8
|
|
Andorfer, C A; Davies, P (2000) PKA phosphorylations on tau: developmental studies in the mouse. Dev Neurosci 22:303-9
|
Showing the most recent 10 out of 34 publications
